Childrens Zyrtec
NDC 50580-790, Cetirizine hydrochloride, tablet, chewable, from Kenvue Brands LLC.
- Product NDC
- 50580-790
- Status
- Listed
- Labeler
- Kenvue Brands LLC
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA021621
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50580-790 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CETIRIZINE HYDROCHLORIDE2.5 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50580-790-01 | 50580079001 | 2 BLISTER PACK in 1 CARTON (50580-790-01) / 6 TABLET, CHEWABLE in 1 BLISTER PACK |
| 50580-790-02 | 50580079002 | 4 BLISTER PACK in 1 CARTON (50580-790-02) / 6 TABLET, CHEWABLE in 1 BLISTER PACK |
| 50580-790-03 | 50580079003 | 1 BLISTER PACK in 1 CARTON (50580-790-03) / 6 TABLET, CHEWABLE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50580-790 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50580-790 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50580-790. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.